Andreas Weigert Selected Research

Interleukin-1 (Interleukin 1)

1/2022	Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer.
1/2021	IL-38 Ablation Reduces Local Inflammation and Disease Severity in Experimental Autoimmune Encephalomyelitis.
11/2020	IL-36 family cytokines in protective versus destructive inflammation.
1/2019	IL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells.
11/2016	IL-1 family cytokines in cancer immunity - a matter of life and death.
10/2016	Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Weigert Research Topics

Disease

79	Neoplasms (Cancer) 04/2024 - 10/2007
36	Inflammation (Inflammations) 01/2024 - 01/2011
16	Hypoxia (Hypoxemia) 02/2024 - 09/2008
15	Neoplasm Metastasis (Metastasis) 02/2022 - 02/2015
14	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2012
11	Lung Neoplasms (Lung Cancer) 01/2023 - 03/2009
7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2024 - 01/2017
7	Colitis 02/2022 - 10/2011
6	Atherosclerosis 01/2023 - 01/2009
5	Neuralgia (Stump Neuralgia) 10/2022 - 03/2014
5	Carcinogenesis 07/2021 - 01/2019
5	Sepsis (Septicemia) 03/2020 - 07/2011
4	Colonic Neoplasms (Colon Cancer) 01/2024 - 05/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 05/2011
4	Peritonitis 11/2023 - 01/2020
4	Carcinoma (Carcinomatosis) 01/2023 - 01/2019
4	Colitis-Associated Neoplasms 02/2022 - 01/2019
3	Leukemia 04/2024 - 07/2014
3	Pain (Aches) 10/2022 - 03/2014
3	Fibrosis (Cirrhosis) 03/2019 - 01/2019
3	Hyperalgesia 01/2018 - 12/2012
2	Fibrosarcoma 02/2024 - 09/2017
2	Adenocarcinoma 12/2023 - 10/2023
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 01/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 01/2023
2	Acute-On-Chronic Liver Failure 01/2023 - 03/2019
2	Myocardial Infarction 01/2023 - 01/2023
2	Neointima 01/2023 - 01/2021
2	Starvation 12/2022 - 01/2021
2	Neuroinflammatory Diseases 10/2022 - 01/2011
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2022 - 01/2019
2	Necrosis 01/2022 - 10/2013
2	COVID-19 01/2022 - 09/2021
2	Disease Progression 01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2009
18	CytokinesIBA 01/2023 - 08/2010
12	LipidsIBA 04/2024 - 03/2009
11	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022 - 10/2007
10	EnzymesIBA 01/2024 - 11/2009
10	Dinoprostone (PGE2)FDA Link 11/2023 - 12/2012
9	Lipocalin-2IBA 03/2021 - 12/2011
8	ProstaglandinsIBA 10/2023 - 01/2011
7	Messenger RNA (mRNA)IBA 02/2024 - 09/2009
7	ZymosanIBA 01/2024 - 01/2018
7	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2019
7	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 01/2009
6	Imiquimod (Aldara)FDA LinkGeneric 01/2024 - 01/2017
6	Interleukin-1 (Interleukin 1)IBA 01/2022 - 10/2016
6	Conditioned Culture MediaIBA 01/2020 - 10/2007
6	sphingosine kinaseIBA 01/2019 - 01/2009
5	IronIBA 02/2024 - 01/2017
5	SphingolipidsIBA 01/2024 - 01/2019
5	Transcription Factors (Transcription Factor)IBA 01/2022 - 07/2011
5	LigandsIBA 11/2021 - 06/2015
5	Interleukin-12 (IL 12)IBA 10/2020 - 11/2009
5	Interleukin-10 (Interleukin 10)IBA 01/2020 - 11/2009
4	Dextrans (Dextran)FDA Link 02/2022 - 10/2011
4	Prostaglandin-E SynthasesIBA 01/2022 - 01/2011
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2017
4	InterleukinsIBA 07/2020 - 01/2013
4	Prostaglandins EIBA 10/2013 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2020
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024 - 01/2020
3	dihydroceramide desaturaseIBA 01/2024 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 10/2014
3	AntigensIBA 01/2023 - 01/2009
3	AzoxymethaneIBA 02/2022 - 01/2018
3	Tamoxifen FDA LinkGeneric 01/2022 - 12/2019
3	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2021 - 01/2019
3	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2020 - 01/2018
3	Phosphotransferases (Kinase)IBA 07/2020 - 10/2017
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2020 - 10/2011
3	Interleukin-27 (Interleukin 27)IBA 01/2020 - 06/2012
3	Neutralizing AntibodiesIBA 01/2020 - 01/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019 - 09/2008
3	Oxygen (Dioxygen)IBA 10/2018 - 09/2008
3	Interleukin-6 (Interleukin 6)IBA 10/2017 - 01/2013
2	PhosphatidylserinesIBA 04/2024 - 01/2022
2	Small Interfering RNA (siRNA)IBA 02/2024 - 03/2009
2	LeukotrienesIBA 01/2024 - 01/2018
2	Interleukin-4 (Interleukin 4)IBA 01/2024 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2023 - 10/2013
2	Meloxicam (Mobic)FDA LinkGeneric 10/2023 - 03/2014
2	Sirolimus (Rapamycin)FDA Link 12/2022 - 10/2017
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2022 - 07/2021
2	Cyclooxygenase InhibitorsIBA 01/2022 - 03/2014
2	AntibodiesIBA 09/2021 - 01/2020
2	Epoxy Compounds (Epoxides)IBA 07/2021 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2013

Therapy/Procedure

25	Therapeutics 10/2023 - 01/2009
8	Immunotherapy 04/2024 - 01/2009
5	Ligation 12/2019 - 07/2011
4	Punctures 01/2019 - 07/2011
3	Drug Therapy (Chemotherapy) 10/2022 - 01/2020
2	Adjuvant Chemotherapy 11/2023 - 01/2023
2	Chemoradiotherapy 01/2023 - 01/2022
2	Radiotherapy 01/2023 - 06/2012
2	Neoadjuvant Therapy 01/2022 - 01/2022